Luminex Builds Genetic Test Portfolio Via Tm Bioscience Acquisition
This article was originally published in The Gray Sheet
Executive Summary
Luminex's purchase of DNA-based test maker Tm Bioscience gives the firm full ownership of comprehensive molecular diagnostic kits previously produced collaboratively by the companies